VPT — VentriPoint Diagnostics Income Statement
0.000.00%
Last trade - 00:00- CA$23.64m
- CA$24.93m
- CA$0.05m
Annual income statement for VentriPoint Diagnostics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.081 | 0.036 | 0 | 0.068 | 0.049 |
| Cost of Revenue | |||||
| Gross Profit | 0.037 | 0.026 | -0.006 | 0.058 | 0.042 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.4 | 1.91 | 3.8 | 4.98 | 4.98 |
| Operating Profit | -3.32 | -1.87 | -3.8 | -4.91 | -4.93 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.32 | -1.85 | -3.88 | -4.87 | -4.87 |
| Net Income After Taxes | -3.32 | -1.85 | -3.88 | -4.87 | -4.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.32 | -1.85 | -3.88 | -4.87 | -4.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.32 | -1.85 | -3.88 | -4.87 | -4.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.052 | -0.025 | -0.028 | -0.031 | -0.031 |